Abstract P5-09-29: Trastuzumab Combined with Pyrotinib and Capecitabine as Postoperative Adjuvant Therapy in Non-Pathological Complete Response HER2-Positive Early Breast Cancer Following Neoadjuvant Therapy: A Multicenter Phase II StudyChuan Wang, Zhe Zhang, Shunguo Lin et al.|Clinical Cancer Research|2025Cited by 0